NeoGenomics
NEO
#4700
Rank
A$3.16 B
Marketcap
A$24.43
Share price
2.12%
Change (1 day)
52.65%
Change (1 year)

Earnings for NeoGenomics (NEO)

Earnings in 2026 (TTM): -A$48.12 Million

According to NeoGenomics 's latest financial reports the company's current earnings are A$0.78 Billion. In 2025 the company made an earning of -A$0.16 Billion a decrease over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NeoGenomics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$48.12 Million-68.86%
2025 -A$0.16 Billion43.83%
2024 -A$0.11 Billion-15.36%
2023 -A$0.13 Billion-44.48%
2022 -A$0.23 Billion54.74%
2021 -A$0.15 Billion1347.28%
2020 -A$10.21 Million-195.64%
2019 A$10.67 M-26.82%
2018 A$14.58 M194.06%
2017 A$4.96 M32.78%
2016 A$3.73 M-170.84%
2015 -A$5.28 Million-263.89%
2014 A$3.21 M-30.1%
2013 A$4.6 M161.8%
2012 A$1.75 M
2010 -A$4.3 Million71.51%
2009 -A$2.51 Million95.43%
2008 -A$1.29 Million-72.72%
2007 -A$4.71 Million-5353.35%
2006 A$0.08 M-107.71%
2005 -A$1.17 Million9.7%
2004 -A$1.06 Million47.59%
2003 -A$0.72 Million700.47%
2002 -A$0.09 Million
2000 -A$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Quest Diagnostics
DGX
A$2.16 B-4,630.27%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$2.11 B-4,535.84%๐Ÿ‡บ๐Ÿ‡ธ USA
RadNet
RDNT
A$0.15 B-422.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-A$2.78 Million-94.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-A$11.38 Million-76.19%๐Ÿ‡บ๐Ÿ‡ธ USA